Ardent Health Reports Third Quarter 2026 Results
Key Highlights
- ➤Q3 revenue $1.625 billion, up 3.1% year-over-year
- ➤Q3 net income $45 million versus $23 million loss
- ➤Adjusted EBITDA $138 million; adjusted admissions rose 2.9%
- ➤2026 adjusted EBITDA guidance raised to $500-$535 million
- ➤Board increased share repurchase authorization by $25 million
Expert Statements
Dave Caspers, President and Chief Executive Officer of Ardent Health
“We delivered strong third quarter results, highlighted by adjusted EBITDA of $138 million, a 4% reduction in SWB expense, and 2.9% adjusted admissions growth,”
Dave Caspers, President and Chief Executive Officer of Ardent Health
“Our performance reflects disciplined execution, with volumes improving sequentially and continued progress on our operating priorities. IMPACT initiatives continued to gain traction and remain on track to achieve at least $70 million of savings this year, contributing to greater efficiency and stronger financial performance.”
Dave Caspers, President and Chief Executive Officer of Ardent Health
“We enter the fourth quarter with confidence in the trajectory of our business and ability to execute on the opportunities ahead,”
Dave Caspers, President and Chief Executive Officer of Ardent Health
“Based on our year-to-date performance and continued operational momentum, we are raising our 2026 Adjusted EBITDA guidance midpoint 1.5%.”
Dave Caspers, President and Chief Executive Officer of Ardent Health
“Consistent with our focus on disciplined portfolio management, we entered into a definitive agreement during the third quarter to transition full ownership of our Kansas hospital to our joint venture partner,”
Dave Caspers, President and Chief Executive Officer of Ardent Health
“We expect this transaction to enhance margins while allowing us to redeploy capital toward growth in core markets where we can build scale and integrated systems of care.”
Dave Caspers, President and Chief Executive Officer of Ardent Health
“We remain focused on strategic capital deployment that prioritizes organic investments and M&A,”
Dave Caspers, President and Chief Executive Officer of Ardent Health
“The company’s $766 million of cash and 2.5x lease-adjusted net leverage provide flexibility to execute against these priorities while maintaining a balanced approach to capital allocation that creates long-term shareholder value.”
Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended September 30, 2026.
All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue Net Income Attributable to Ardent Health
Get started
Create a free account to read the full story.